Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ESCALATE-RA A NON-INTERVENTIONAL STUDY OF CRITICAL FACTORS FOR ESCALATING DRUG TREATMENT IN PATIENTS TREATED WITH TOFACITINIB FOR MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS

NCT03387423 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03387423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03387423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ESCALATE-RA A NON-INTERVENTIONAL STUDY OF CRITICAL FACTORS FOR ESCALATING DRUG TREATMENT IN PATIENTS TREATED WITH TOFACITINIB FOR MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 2, 2017
Completion date
July 17, 2023
Enrollment
1,459 (actual)
Sites
91

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid